Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Gene record

TSC22D4

TSC22 domain family member 4

translation score 0.41, read 2026-10-24; 2 sealed predictions, 0 held; 3 receipts.

Six readers

readerfoundscore
genetics
Open Targets
no genetic evidence; overall 0.02 from other evidence0.00
cell type
Human Protein Atlas
cell type enhanced, including oligodendrocytes; strongest in müller glia0.75
chemistry
Open Targets
hard to drug0.00
trials
ClinicalTrials.gov
no Parkinson's trials on record: an open field1.00
literature
PubMed
no papers tie it to Parkinson's yet1.00
pathways
Reactome
in no curated pathway0.00

No case: the score is under the bar. Receipt 8479

Sealed predictions

  1. TSC22D4 in dopamine neurons, braak-0.34 (p 0.374) → -0.34 (p 0.373)receipt 8487
  2. TSC22D4 in oligodendrocytes, braak+0.00 (p 1.000) → +0.00 (p 1.000)receipt 8486

Swarm cases

receipt 8487: TSC22D4 in dopamine neurons, braak

power
full sample -0.35 (p 0.156, n 18), 95% CI -0.70 to +0.14. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: -0.35 (p 0.156, n 18). does not hold up.
composition
dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.35 (p 0.150, n 18). could be the mix.
skeptic
leave-one-out range -0.44 to -0.25, sign flips 0; without severely affected donors -0.35 (p 0.156, n 18). fragile.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for TSC22D4 in dopamine neurons.

case closed: nothing better to follow up.

receipt 8486: TSC22D4 in oligodendrocytes, braak

power
full sample +0.00 (p 0.990, n 18), 95% CI -0.46 to +0.47. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: -0.02 (p 0.935, n 18). does not hold up.
composition
oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: -0.01 (p 0.983, n 18). could be the mix.
skeptic
leave-one-out range -0.12 to +0.12, sign flips 8; without severely affected donors +0.00 (p 0.990, n 18). fragile.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for TSC22D4 in oligodendrocytes.

case closed: nothing better to follow up.

Receipts

loading the receipts